E74.02
BillablePompe disease
Pompe disease
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Cardiac glycogenosis
- Type II glycogen storage disease
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)
- androgen insensitivity syndrome (E34.5-)
- congenital adrenal hyperplasia (E25.0)
- hemolytic anemias attributable to enzyme disorders (D55.-)
- Marfan syndrome (Q87.4-)
- 5-alpha-reductase deficiency (E29.1)
- diabetes mellitus (E08-E13)
- hypoglycemia NOS (E16.2)
- increased secretion of glucagon (E16.3)
- mucopolysaccharidosis (E76.0-E76.3)
Excludes 2
Conditions not included here, but the patient may have both
- Ehlers-Danlos syndromes (Q79.6-)
Also Known As / Clinical Terms
SNOMED CT
- Deficiency of acid maltase124454007
- Deficiency of amyloglucosidase124454007
- Deficiency of exo-1,4-alpha-glucosidase124454007
- Deficiency of gamma-amylase124454007
- Deficiency of glucan 1,4-alpha-glucosidase124454007
- Deficiency of glucoamylase124454007
- Deficiency of alpha-glucosidase124462004
- Deficiency of glucoinvertase124462004
- Deficiency of glucosidosucrase124462004
- Deficiency of maltase124462004
- Cardiac glycogenosis195025008
- Alpha-1,4-glucosidase acid deficiency274864009
- Glycogen heart disease274864009
- Glycogen storage disease due to acid maltase deficiency274864009
- Glycogen storage disease, type II274864009
- Glycogenosis due to acid maltase deficiency274864009
- Glycogenosis type II274864009
- Pompe disease274864009
- Pompe's disease274864009
- Fatal congenital nonlysosomal heart glycogenosis459062008
- Glycogen storage disease type 15717821004
- Glycogen storage disease type XV717821004
- Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency717821004
- Glycogenosis with severe cardiomyopathy due to glycogenin deficiency717821004
- Glycogen storage disease due to acid maltase deficiency, infantile onset722302009
- Glycogen storage disease type II infantile onset722302009
- Glycogenosis due to acid maltase deficiency, infantile onset722302009
- Glycogenosis type II, infantile onset722302009
- Pompe disease, infantile onset722302009
- Alpha-1,4-glucosidase acid deficiency, late onset722343009
- Glycogen storage disease due to acid maltase deficiency, late-onset722343009
- Glycogen storage disease type II late onset722343009
- Glycogenosis type II, late onset722343009
- Pompe disease, late onset722343009
- Infiltrative cardiomyopathy871646007
- Lysosomal storage disease28821000119102
UMLS
- 2 glycogenosisC0017921
- ACID ALPHA-GLUCOSIDASE DEFICIENCYC0017921
- ACID MALTASE DEFIC DISC0017921
- ACID MALTASE DEFICIENCYC0017921
- ALPHA-1,4-GLUCOSIDASE DEFICIENCYC0017921
- AMDC0017921
- Acid Alpha Glucosidase DeficiencyC0017921
- Acid Alpha-Glucosidase DeficienciesC0017921
- Acid Alpha-Glucosidase DeficiencyC0017921
- Acid Maltase Deficiency DiseaseC0017921
- Acid maltase deficiency diseaseC0017921
- Alpha-1,4-glucosidase acid deficiencyC0017921
- Alpha-1,4-glucosidase deficiencyC0017921
- Alpha-Glucosidase DeficienciesC0017921
- Alpha-Glucosidase Deficiencies, AcidC0017921
- Alpha-Glucosidase DeficiencyC0017921
- Alpha-Glucosidase Deficiency, AcidC0017921
- DEFIC DIS ACID MALTASEC0017921
- DEFIC DIS LYSOSOMAL ALPHA 1 4 GLUCOSIDASEC0017921
- Deficiencies, Acid Alpha-GlucosidaseC0017921
- Deficiencies, GAAC0017921
- Deficiency Disease, Acid MaltaseC0017921
- Deficiency Disease, Lysosomal alpha-1,4-GlucosidaseC0017921
- Deficiency of Alpha GlucosidaseC0017921
- Deficiency of Alpha-GlucosidaseC0017921
- Deficiency, Acid Alpha-GlucosidaseC0017921
- Deficiency, GAAC0017921
- Disease, PompeC0017921
- Disease, Pompe'sC0017921
- GAA DEFICIENCYC0017921
- GAA DeficienciesC0017921
- GAA DeficiencyC0017921
- GAA deficiencyC0017921
- GLYCOGEN STORAGE DIS IIC0017921
- GLYCOGEN STORAGE DISEASE IIC0017921
- GSD IIC0017921
- GSD2C0017921
- GSD2sC0017921
- Generalized GlycogenosesC0017921
- Generalized GlycogenosisC0017921
- Glycogen Storage Disease IIC0017921
- Glycogen Storage Disease Type 2C0017921
- Glycogen Storage Disease Type IIC0017921
- Glycogen heart diseaseC0017921
- Glycogen storage disease due to acid maltase deficiencyC0017921
- Glycogen storage disease due to acid maltase deficiency (disorder)C0017921
- Glycogen storage disease type IIC0017921
- Glycogen storage disease, type IIC0017921
- Glycogenoses, GeneralizedC0017921
- Glycogenosis 2C0017921
- Glycogenosis Type IIC0017921
- Glycogenosis due to acid maltase deficiencyC0017921
- Glycogenosis type IIC0017921
- Glycogenosis, GeneralizedC0017921
- LYSOSOMAL ALPHA 1 4 GLUCOSIDASE DEFIC DISC0017921
- Lysosomal alpha 1,4 Glucosidase Deficiency DiseaseC0017921
- Lysosomal alpha-1,4-Glucosidase Deficiency DiseaseC0017921
- POMPE DISC0017921
- POMPE DISEASEC0017921
- POMPES DISC0017921
- Pompe DiseaseC0017921
- Pompe diseaseC0017921
- Pompe's DiseaseC0017921
- Pompe's diseaseC0017921
- Pompes DiseaseC0017921
- Type II glycogen storage diseaseC0017921
- Type II, GlycogenosisC0017921
- Type IIs, GlycogenosisC0017921
- acid maltase deficiencyC0017921
- alpha 1,4 glucosidase deficiencyC0017921
- disease pompe'sC0017921
- generalized glycogenosisC0017921
- glycogen storage disease type IIC0017921
- glycogen storage disease type iiC0017921
- glycogenosis type IIC0017921
- maltase acid deficiencyC0017921
- maltase deficiencyC0017921
- pompe diseaseC0017921
- pompe's diseaseC0017921
- pompes diseaseC0017921
- Cardiac glycogenosisC0340420
- Cardiac glycogenosis (disorder)C0340420
Frequently Asked Questions
What is the ICD-10 code for pompe disease?
The ICD-10-CM code for pompe disease is E74.02. The full clinical description is "Pompe disease". E74.02 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code E74.02 mean?
ICD-10-CM code E74.02 represents "Pompe disease". It is classified under Chapter 4: Endocrine, Nutritional and Metabolic Diseases and is a billable/specific code that can be used on a claim.
Is E74.02 a billable code?
Yes, E74.02 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is E74.02 in?
E74.02 is in Chapter 4: Endocrine, Nutritional and Metabolic Diseases (codes E00-E89).
What codes cannot be used with E74.02?
E74.02 has Excludes1 notes indicating codes that cannot be used together with it, including: transitory endocrine and metabolic disorders specific to newborn (P70-P74); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); and 7 more.
What SNOMED CT codes does E74.02 map to?
E74.02 maps to 10 SNOMED CT concepts: 274864009, 722343009, 195025008, 124454007, 124462004, and 5 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for E74.02?
E74.02 is linked to 2 UMLS Concept Unique Identifiers: C0017921, C0340420. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.